Investigators at NYU Langone’s Center for the Prevention of Cardiovascular Disease study the mechanisms underlying the development, progression, and stabilization of cardiovascular disease and related conditions through basic, translational, clinical, and population-based research.

Clinical Trials in Preventive Cardiology

Our center is currently involved in enrolling subjects in several investigator-initiated, National Institutes of Health- and American Heart Association-funded and industry-sponsored phase I to phase 3 clinical trials and is consistently a robust site of recruitment for clinical trials in cardiology.

Our areas of investigation include targeting of low-density lipoprotein (LDL) cholesterol and lipoprotein(a) levels; LDL lowering and other new treatments in diabetes mellitus type 2; the effect of environmental exposure in patients with diabetes mellitus type 2; the relationship between obesity and high-density lipoprotein function; chelation therapy; and mechanisms of clotting and optimal dosage of anticoagulation therapy in COVID-19 patients. Learn more about our clinical trials conducted through the Division of Cardiology.

Marc and Ruti Bell Vascular Biology and Disease Program

Our researchers used advanced techniques to study the cellular and molecular mechanisms of disease at the Marc and Ruti Bell Vascular Biology and Disease Program.

Basic and Translational Laboratories

Several of our researchers also conduct basic and translational studies through their own labs. Learn more about the Center for the Prevention of Cardiovascular Disease’s basic and translational research.